JUN 2026
Swixx BioPharma was created to replace biopharma, OTC and medical device multinationals’ subsidiaries in those countries, or therapeutic areas, that our partners choose not to enter, or to exit
Swixx BioPharma was created to replace biopharma, OTC and medical device multinationals’ subsidiaries in those countries, or therapeutic areas, that our partners choose not to enter, or to exit. Over the past decade, we have swiftly evolved into one of the largest, most professional and reliable partners in the countries of Central & Eastern Europe, Russia/Eurasia and Greece for international healthcare companies.